Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AZD-6793 by AstraZeneca for Inflammation: Likelihood of Approval
AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Inflammation. According to GlobalData, Phase I drugs...
Data Insights
AZD-6793 by AstraZeneca for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD). According to...